GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Total Assets

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Total Assets : $7,476 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings Total Assets?

Aspen Pharmacare Holdings's Total Assets for the quarter that ended in Dec. 2023 was $7,476 Mil.

During the past 12 months, Aspen Pharmacare Holdings's average Total Assets Growth Rate was 13.50% per year. During the past 3 years, the average Total Assets Growth Rate was -0.70% per year. During the past 5 years, the average Total Assets Growth Rate was -1.00% per year. During the past 10 years, the average Total Assets Growth Rate was 8.00% per year.

During the past 13 years, Aspen Pharmacare Holdings's highest 3-Year average Total Assets Growth Rate was 58.90%. The lowest was -5.80%. And the median was 34.10%.

Total Assets is connected with ROA %. Aspen Pharmacare Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was 3.39%. Total Assets is also linked to Revenue through Asset Turnover. Aspen Pharmacare Holdings's Asset Turnover for the quarter that ended in Dec. 2023 was 0.16.


Aspen Pharmacare Holdings Total Assets Historical Data

The historical data trend for Aspen Pharmacare Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Total Assets Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,386.42 7,772.12 7,883.51 7,042.63 7,163.80

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,383.90 7,042.63 6,977.78 7,163.80 7,475.63

Aspen Pharmacare Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aspen Pharmacare Holdings's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (A: Jun. 2023 )+Total Liabilities (A: Jun. 2023 )
=4600.529+2563.271
=7,164

Aspen Pharmacare Holdings's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=4594.049+2881.585
=7,476

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aspen Pharmacare Holdings  (OTCPK:APNHY) Total Assets Explanation

Total Assets is connected with ROA %.

Aspen Pharmacare Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=248.38/( (7163.8+7475.634)/ 2 )
=248.38/7319.717
=3.39 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aspen Pharmacare Holdings's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1134.612/( (7163.8+7475.634)/ 2 )
=1134.612/7319.717
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aspen Pharmacare Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019